Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers

2012 ◽  
Vol 52 (7) ◽  
pp. 1007-1016 ◽  
Author(s):  
Himanshu Naik ◽  
Majid Vakilynejad ◽  
Jingtao Wu ◽  
Prabhakar Viswanathan ◽  
Nobuhito Dote ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document